|
Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified medical advice, visits or professional assistance with a genuine dr.. We are not doctors. Always consult your mD about Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer Clinical research trials and Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer medical trials take place in many of places throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new does drugs. The purpose of the studies / projects is to solve specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to find cures for all varieties of conditions, like Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer. Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer Clinical Trials and other clinical trials allow for volunteers to have health treatment options before they are available to the masses. Many times the human subjects acquire professional assistance for free of charge, and sometimes they are compensated for their time. Occasionally there is a cost for a Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer clinical trial. Test subjects typically obtain the finest healthcare available for their Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer condition. Dangers are a reality, nevertheless, and might include additional or frequent doctor trips, medical dangers (possibly life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "Q" Clinical Trials Conditions > Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer  Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
For Condition: stage 4 ovarian germ cell tumor,stage 1 ovarian germ cell tumor,recurrent ovarian germ cell tumor,stage 3 ovarian germ cell tumor,stage 2 ovarian germ cell tumor,Quality of Life
Status: No longer recruiting
Sponsor(s): National Cancer Institute (NCI) , Gynecologic Oncology Group
Synopsis: RATIONALE: Quality-of-life assessment of patients undergoing cancer treatment may help determine the intermediate- and long-term effects of treatment in patients with cancer. PURPOSE: Clinical trial to determine the quality of life of patients who have previously treated ovarian cancer.
Details: OBJECTIVES: I. Compare quality of life in terms of health status, sexual functioning, psychological/emotional well being, and social functioning in ovarian germ cell cancer survivors vs a matched healthy control group. II. Predict quality of life in these patients through the additive effects of cancer diagnosis and treatment, sociodemographic characteristics, other stressors, and social network variables. PROTOCOL OUTLINE: Patients identify up to 3 healthy acquaintance controls within 3 years of the same age. Patients and controls complete a written questionnaire, which takes about 30 minutes, and a telephone interview, which takes about 1 hour, to assess quality of life. PROJECTED ACCRUAL: A total of 190 patients and 190 healthy controls will be accrued for this study within 2 years.
Eligibility:
Study Type: Interventional, Educational/Counseling/Training
Minimum Age/Maximum Age: 18 Years/
Genders:
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- - History of early or advanced ovarian germ cell tumors - Continuously disease free for at least 2 years prior to study - Must have been enrolled on GOG protocols 45, 78, 90, and 116 or similar protocols of cisplatin-based chemotherapy at M.D. Anderson Cancer Center --Prior/Concurrent Therapy-- - Biologic therapy: Not specified - Chemotherapy: See Disease Characteristics - Endocrine therapy: Not specified - Radiotherapy: No prior radiotherapy - Surgery: Not specified --Patient Characteristics-- - Age: 18 and over - Performance status: Not specified - Life expectancy: Not specified - Hematopoietic: Not specified - Hepatic: Not specified - Renal: Not specified - Other: Must be able to complete a written questionnaire and telephone interview in English
Total Enrollment:
Location and Contact Information:
Overall Study Official:
StephenWilliams, Study Chair, Gynecologic Oncology Group
Indiana University Cancer Center
Indianapolis, Indiana, 46202-5289
United States
Chao Family Comprehensive Cancer Center
Orange, California, 92868
United States
University of Texas - MD Anderson Cancer Center
Houston, Texas, 77030-4009
United States
Evanston Northwestern Health Care
Evanston, Illinois, 60201
United States
Additional Information:
Study ID Numbers: CDR0000066937; GOG-9901
Study Start Date: April 1999
Record last reviewed: October 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00003794
Other Stage 3 Ovarian Germ Cell Tumor Studies:
1. Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
2. Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
Related Studies:
Other stage 3 ovarian germ cell tumor Clinical Trials
Other Texas Clinical Trials
Other Houston Clinical Trials
Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
|
|
|
|
|
|
|
|
